Summary
ISQI Chart
2 Brilliant Biotech ETFs to Watch in 2026
As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look to opportunities to be had within other sectors.
Inside the Recent Strength in Biotech ETFs
Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.
Biotech ETFs Hovering Around a 52-Week: Here's Why
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied 26.1% over the past six months (as of Oct. 27, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 24.4%). Year to date, IBB has risen 18.2% versus SPY's 17.2% gain.
iShares Biotechnology ETF (ISQI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has iShares Biotechnology ETF ever had a stock split?
iShares Biotechnology ETF Profile
| XMUN Exchange | US Country |
Overview
The described company operates as an investment fund focused on tracking the performance of a specific underlying index. By investing at least 80% of its assets in the securities that comprise the index, the fund aims to mimic the index's returns and behavior closely. This strategy indicates a focus on providing investors with exposure to the components of a particular market or sector through the index it follows. However, it is noteworthy that the fund is characterized as non-diverse, which means it may concentrate its investments in a particular sector, company, or geographical area, potentially increasing the risk of volatility and loss due to lack of diversification.
Products and Services
The fund offers a targeted investment product that primarily focuses on securities from its underlying index, alongside additional financial instruments to potentially enhance returns and manage risks:
- Component Securities Investments: The core of the fund's portfolio comprises at least 80% investment in the securities that are part of the underlying index it tracks. This approach is designed to replicate the performance of the index, offering investors exposure to its specified market or sector.
- Futures, Options, and Swap Contracts: Up to 20% of the fund's assets may be allocated to futures, options, and swap contracts. These derivative financial instruments can serve multiple purposes, including hedging against market volatility, leveraging to amplify returns, and speculative investment opportunities, allowing the fund to potentially enhance its overall performance.
- Cash and Cash Equivalents: A portion of the fund's assets may be held in cash or cash equivalents. This allocation is strategic, enabling the fund to manage liquidity effectively, meet redemption requests promptly, and take advantage of new investment opportunities as they arise. Holding cash and cash equivalents can also provide a buffer against market downturns.
Contact Information
